OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Ophthalmology is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Bilateral Central and Peripheral Vision Loss in an Otherwise Asymptomatic Woman	194
Addressing the Challenges of Smartphone-Based Telescreening for Retinopathy of Prematurity	138
Gravitational Shifting of a Pigmented Iris Lesion in a Young Boy	135
Intravitreal Glioma in a Boy Aged 7 Years	127
Update to Open Access Status	108
Unmet Needs in Vision Care Among Vulnerable Patients	101
Scleral Histopathologic Findings of Hurler-Scheie Syndrome With Refractory Glaucoma	99
Taking Steps to Advance Health Equity in Ophthalmology	95
Congenital Lamellar and Sutural Cataract in a Patient With Type 2 Diabetes	92
Pseudorheumatoid Nodules of the Eyelid in a Boy Aged 4 Years	92
Error in a Supplement	89
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	86
Do Not Think of a Purple Wolf—Keratoconus, ADHD, and Itch	81
Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma	81
Evaluating the Entire Shape of the Eye With Pathologic Myopia	78
Sudden-Onset Bilateral Mydriasis in a Young Girl	74
Diabetic Retinopathy in Pregnancy	71
JAMA Ophthalmology	62
Considerations When Using a Statistical Learning Model to Predict Corneal Edema Resolution—Reply	61
Do Racial/Ethnic Disparities in Rates of Enucleation for Uveal Melanoma Indicate Poor Quality of Care or Financial Obstacles?—Reply	60
JAMA Ophthalmology	58
Blurred Vision in a Young Woman With Cosmetic Iris Implants	57
Numerous Peripheral Retinal Yellow Flecks in an Adult Woman	53
Questions Regarding the 2019 Quality Payment Program Performance for Ophthalmologists	50
Correction to Data Points in Figure	50

Plasma Levels of Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity Study—More Questions Than Answers	49
Small Payments, Large Consequences	48
Risk Factors Associated With Pterygium Reoperation in the IRIS Registry	47
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema	46
Association Between Myopic Refractive Error and Primary Open-Angle Glaucoma	46
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study	45
Homonymous Hemianopia With Normal Neuroimaging	44
Effect of Nightly Lower Body Negative Pressure on Choroid Engorgement in a Model of Spaceflight-Associated Neuro-ocular Syndrome	44
Oculocutaneous Albinism	44
Photokeratitis in Outdoor Event Participants Exposed to UV Radiation Display	43
Multidrug-Resistant Pseudomonas aeruginosa Keratitis Associated With Artificial Tear Use	43
Changes in Optic Nerve Head and Retinal Morphology During Spaceflight and Acute Fluid Shift Reversal	43
Severe Spaceflight-Associated Neuro-Ocular Syndrome in an Astronaut With 2 Predisposing Factors	43
Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study	42
Longitudinal Trends and Disparities in Diabetic Retinopathy Within an Aggregate Health Care Network	42
Structural and Functional Retinal Changes in Preclinical Alzheimer Disease	41